» Articles » PMID: 22320867

Prognostic Significance of Phosphorylated STAT-1 Expression in Premenopausal and Postmenopausal Patients with Invasive Breast Cancer

Overview
Journal Histopathology
Date 2012 Feb 11
PMID 22320867
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Aims:   STAT-1 is the first member of the family of signal transducers and activators of transcription (STATs). In breast cancer experimental models, an apoptotic and antiproliferative effect has been demonstrated. Our aim was to study the role of phosphorylated STAT-1 (pSTAT-1) in invasive breast carcinoma and its prognostic significance in premenopausal and postmenopausal patients.

Methods And Results:   Immunohistochemistry was performed in 165 patients in order to detect the expression of pSTAT-1 and its correlation with oestrogen receptor (ER), progesterone receptor (PR), caspase-3, and pAkt. pSTAT-1 was immunodetected in the cytoplasm of the malignant cells (11.6%). In premenopausal patients, cytoplasmic pSTAT-1 was positively correlated with stage (P = 0.014), ER (P = 0.008), caspase-3 (P = 0.029), and pAkt (P = 0.045). Univariate analysis showed that cytoplasmic pSTAT-1 was associated with poor overall survival (P = 0.042) and the phenotype of pSTAT-1/ER or PR coexpression with shorter disease-free survival (P = 0.012). In contrast, in postmenopausal patients, no association with clinicopathological parameters and survival was observed, except for the relationship of pSTAT-1/ER or PR coexpression with longer disease-free survival (P = 0.034).

Conclusions:   This is the first study examining the role of pSTAT-1 in premenopausal and postmenopausal women with invasive breast cancer. Our results suggest that pSTAT-1 is related to tumour progression in premenopausal patients through the advanced stage and worse survival.

Citing Articles

STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC.

Li Y, Jiang F, Zhu S, Jia H, Li C Front Mol Biosci. 2024; 11:1419072.

PMID: 38948079 PMC: 11211654. DOI: 10.3389/fmolb.2024.1419072.


cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer.

Chen M, Yu S, van der Sluis T, Zwager M, Schroder C, van der Vegt B NPJ Breast Cancer. 2024; 10(1):1.

PMID: 38167507 PMC: 10761738. DOI: 10.1038/s41523-023-00609-z.


Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy.

Han J, Wu M, Liu Z Front Immunol. 2023; 14:1190333.

PMID: 37275859 PMC: 10233742. DOI: 10.3389/fimmu.2023.1190333.


Seasonal variation in the morphokinetics of -derived bovine embryos is associated with the blastocyst developmental competence and gene expression.

Yaacobi-Artzi S, Kalo D, Roth Z Front Reprod Health. 2022; 4:1030949.

PMID: 36406891 PMC: 9670144. DOI: 10.3389/frph.2022.1030949.


Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer.

Egelston C, Guo W, Tan J, Avalos C, Simons D, Lim M JCI Insight. 2022; 7(3).

PMID: 35132960 PMC: 8855819. DOI: 10.1172/jci.insight.153963.